themselves taking directions from the white house. the whole thing was like watching synchronized swimming it was an amazing performance but most amazing of all public leaders joining the effort appeared after two years of covid training, they couldn t help themselves. the result was the largest political flash mob in american history. republicans, democrats, business and the media all on one side. so, of course from a distance of any kind was banned. and if you persist to ask questions about all of this found themselves censored up your those who persisted in asking questions if they were lucky to wear a protective platform found themselves threatened with something worse. maybe an indictment, may be. here is former hunter mccaskill threatened on the show last night. tucker carlson and others are really close to treason in terms of what they are saying and what
The required equipment to set up Paediatric Intensive Care Units (ICUs) will arrive in the state by June 10. The GMCH s Super Speciality Block would be the main centre where the facilities for treating children would be set up.
Kupwara: Deputy Commissioner Kupwara, Imam Din today presided over a day long Covid Training programme of Medical officers at ANMT School, here. The training was organized by District Health Society Kupwara under the title “Covid-19 Management and Po
Vaccine dry run on January 2 at all state capitals
Updated Jan 1, 2021, 4:13 am IST
Expert panel to review Biotech and Serum data
There will be 25 test beneficiaries who will be healthcare workers. Their data has to be uploaded in Co-WIN (Covid Vaccine Intelligence Network) app
Hyderabad: The emergency use authorisation of Covaxin by Bharat Biotech and Covishield by Serum Institute of India will be taken up by the subject expert committee on January 1.
Additional data and information about Phase 3 trials has been submitted by both the companies. A review of the data was carried out and the subject expert committee of Central Drugs Standard Control Organisation will analyse it further. Bharat Biotech has carried out Phase 3 trials in more than 13,000 volunteers. Their target is 26,000 volunteers.